M&A
Spire Healthcare surges on report of Mediclinic bid
Private healthcare provider Spire Healthcare surged on Friday following a report that peer Mediclinic was preparing a bid for the remainder of the company.
Dechra buys Apex Lab for AUD$55m
Veterinary product manufacturer Dechra Pharmaceuticals agreed to buy the business and assets of Apex Laboratories, which sells branded animal products in Australia and New Zealand, for AUD$55m (£31. 3m).
Unilever said to be in talks to buy Jessica Alba's Honest
Unilever is said to be in talks to acquire Honest Co. , the consumer-products retailer co-founded by actress Jessica Alba.
Bayer to buy Monsanto for $128 a share
German chemicals and drugs firm Bayer has agreed to buy US seed giant Monsanto for $128 per share in an all-cash transaction that will create a company worth $66bn.
Allergan to buy Vitae Pharmaceuticals in $639m deal
Allergan has agreed to buy clinical-stage biotechnology company Vitae Pharmaceuticals for $21 per share in cash, for a total transaction value of about $639m.
Potash and Agrium agree merger to create fertiliser company with $20.6bn yearly revenue
Canadian fertiliser producers Agrium and Potash have said that the two companies will merge to create a crop company worth around $20. 6bn in annual revenue.
Horizon Pharma to buy Raptor Phartmaceutical in $800m deal
Dublin-based Horizon Pharma has agreed to buy Raptor Pharmaceutical in a deal valued at around $800m.
HarbourVest launches all-cash takeover of SVG Capital
HarbourVest Partners launched an all-cash takeover of FTSE-250 listed SVG Capital, with stock in the latter having moved above the offer price in early trading.
HP to buy Samsung's printer business in $1.05bn deal
HP Inc. has agreed to buy Samsung Electronics Co’s printer business in a deal valued at $1. 05bn.
Vodafone shares may be set to rise by a third, Barron´s says
Shares in Vodafone may rise by a third, according to a report in financial weekly Barron´s.
Praxair and Linde terminate talks
Praxair and Linde have ended preliminary discussions regarding a potential merger.
EU suspends review into Dow-DuPont merger over missing documents
The European Commission said on Friday that it was to suspend the deadline for a review of the merger of Dow Chemical and DuPont, as key documents had not been submitted on time.
Micro Focus agrees $8.8bn merger with Hewlett Packard software arm
Micro Focus International has agreed an $8. 8bn deal to merge with US giant Hewlett Packard Enterprise's software business, including a $400m return of value to the FTSE 100 company's shareholders.
Immedia buys Aberdeen-based AVC Media for £200,000
Digital audio content supplier Immedia’s shares soared on Monday morning, as it bought Aberdeen-based AVC Media for £200,000, to strengthen its multimedia content for clients in retail, sport and education.
Allergan buys assets of gene therapy company RetroSense for $60m
Pharmaceutical group Allergan has acquired almost all the assets of privately-held biotechnology company RetroSense for $60m upfront.
Enbridge to buy Spectra Energy in CAD37bn deal
Canadian pipeline company Enbridge Inc has agreed to buy Houston-based Spectra Energy in an all-stock deal valued at approximately CAD37bn.
Sierra Rutile's proposed merger with Iluka hits snag in Germany
Shares in Mineral sands producer Sierra Rutile fell nearly 17% on Tuesday morning as it was announced that its proposed $375m merger with Australian zinc miner Iluka Resources is to be delayed by a German regulator calling for a longer review of the deal.
Danaher to acquire Cepheid in $4bn deal
US manufacturing company Danaher Corp. is set to buy molecular diagnostics firm Cepheid in a deal worth around $4bn including debt.
Intel to purchase Irish chipmaking firm Movidius in €322m deal
US technology giant Intel has agreed a deal to acquire Irish machine-vision chipmaker Movidius in a transaction thought to be worth around €322m.
Fresenius agrees to $6.42bn deal for Spanish healthcare group Quironsalud
German healthcare company Fresenius said on Monday that it had agreed a $6. 42bn leveraged buy-out for Spanish hospital operator IDC Salud Holding, commonly known as Quironsalud.